Literature DB >> 9862946

The care of HIV-infected adults in the United States. HIV Cost and Services Utilization Study Consortium.

S A Bozzette1, S H Berry, N Duan, M R Frankel, A A Leibowitz, D Lefkowitz, C A Emmons, J W Senterfitt, M L Berk, S C Morton, M F Shapiro.   

Abstract

BACKGROUND AND METHODS: In order to elucidate the medical care of patients with human immunodeficiency virus (HIV) infection in the United States, we randomly sampled HIV-infected adults receiving medical care in the contiguous United States at a facility other than military, prison, or emergency department facility during the first two months of 1996. We interviewed 76 percent of 4042 patients selected from among the patients receiving care from 145 providers in 28 metropolitan areas and 51 providers in 25 rural areas.
RESULTS: During the first two months of 1996, an estimated 231,400 HIV-infected adults (95 percent confidence interval, 162,800 to 300,000) received care. Fifty-nine percent had the acquired immunodeficiency syndrome according to the case definition of the Centers for Disease Control and Prevention, and 91 percent had CD4+ cell counts of less than 500 per cubic millimeter. Eleven percent were 50 years of age or older, 23 percent were women, 33 percent were black, and 49 percent were men who had had sex with men. Forty-six percent had incomes of less than $10,000 per year, 68 percent had public health insurance or no insurance, and 30 percent received care at teaching institutions. The estimated annual direct expenditures for the care of the patients seen during the first two months of 1996 were $5.1 billion; the expenditures for the estimated 335,000 HIV-infected adults seen at least as often as every six months were $6.7 billion, which is about $20,000 per patient per year.
CONCLUSIONS: In this national survey we found that most HIV-infected adults who were receiving medical care had advanced disease. The patient population was disproportionately male, black, and poor. Many Americans with diagnosed or undiagnosed HIV infection are not receiving medical care at least as often as every six months. The total cost of medical care for HIV-infected Americans accounts for less than 1 percent of all direct personal health expenditures in the United States.

Entities:  

Mesh:

Year:  1998        PMID: 9862946     DOI: 10.1056/NEJM199812243392606

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  124 in total

1.  HIV: challenging the health care delivery system.

Authors:  J Levi; J Kates
Journal:  Am J Public Health       Date:  2000-07       Impact factor: 9.308

2.  Causes of hospitalization and perceived access to care among persons newly diagnosed with HIV infection: implications for HIV testing programs.

Authors:  Lokesh Shahani; Christine Hartman; Cathy Troisi; Asha Kapadia; Thomas P Giordano
Journal:  AIDS Patient Care STDS       Date:  2011-12-07       Impact factor: 5.078

3.  Quality primary care for HIV/AIDS: how much HIV/AIDS experience is enough?

Authors:  Valerie E Stone
Journal:  J Gen Intern Med       Date:  2003-02       Impact factor: 5.128

4.  Measuring preferences for health care interventions using conjoint analysis: an application to HIV testing.

Authors:  Kathryn A Phillips; Tara Maddala; F Reed Johnson
Journal:  Health Serv Res       Date:  2002-12       Impact factor: 3.402

5.  Use of HAART among young people living with HIV.

Authors:  W Scott Comulada; Dallas T Swendeman; Mary Jane Rotheram-Borus; Kathy M Mattes; Robert E Weiss
Journal:  Am J Health Behav       Date:  2003 Jul-Aug

6.  Medicaid managed care and coverage of prescription medications.

Authors:  Robert J Buchanan
Journal:  Am J Public Health       Date:  2002-08       Impact factor: 9.308

7.  Proportion of US congregations that have people living with HIV.

Authors:  Steven M Frenk; Mark Chaves
Journal:  J Relig Health       Date:  2012-06

8.  The Serostatus Approach to Fighting the HIV Epidemic: prevention strategies for infected individuals.

Authors:  R S Janssen; D R Holtgrave; R O Valdiserri; M Shepherd; H D Gayle; K M De Cock
Journal:  Am J Public Health       Date:  2001-07       Impact factor: 9.308

9.  The long-term benefits of genotypic resistance testing in patients with extensive prior antiretroviral therapy: a model-based approach.

Authors:  Y Yazdanpanah; M Vray; J Meynard; E Losina; M C Weinstein; L Morand-Joubert; S J Goldie; H E Hsu; R P Walensky; C Dalban; P E Sax; P M Girard; K A Freedberg
Journal:  HIV Med       Date:  2007-10       Impact factor: 3.180

10.  Structures of care in the clinics of the HIV Research Network.

Authors:  Baligh R Yehia; Kelly A Gebo; Perrin B Hicks; P Todd Korthuis; Richard D Moore; Michelande Ridore; William Christopher Mathews
Journal:  AIDS Patient Care STDS       Date:  2008-12       Impact factor: 5.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.